where is the best spot to inject tirzepatide Injection Rotation Map You should rotate your injection

Implications of hyperkalemia in heart failure Drug-induced hyperkalemiaor even the perceived risk of itoften leads to clinician hesitancy in initiating or titrating reninangiotensinaldosterone system inhibitors (RAASi)

Consider reading the Motus (oral) trial results and discussing them with your clinician to see if it fits your plan

Chen says its important to have a conversation with your doctor about what this means for your health and your expectations for taking the medication in the future

Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone

A provider who specializes in obesity medicine can help determine whether tirzepatide is likely to work or whether other approaches, such as combination therapy, adding phentermine , or investigating underlying conditions, make more sense